CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 350 enrolled
Drug / intervention
DHA +1 moredrug
Likely dose
DHA 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00266825
NCT00266825Phase 3Completed
CompareCT.gov

Kansas University DHA Outcome Study (KUDOS)

Susan Carlson, PhD·interventional·Posted Dec 19, 2005·Updated Mar 14, 2016

In Brief

A Phase 3 clinical trial evaluating DHA and Placebo capsule for Pregnancy. Completed, enrolled 350 participants across 2 sites.

Detailed Summary

The purpose of the study is to determine if increasing DHA intake during pregnancy can increase gestation duration and enhance infant and childhood outcomes related to visual acuity, stereoacuity, attention, and distractibility.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 19, 2005
Enrollment StartJan 1, 2006
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 20.5 years ago

Interventions

DHAdrug

600 mg DHA

Placebo capsuleother

Placebo capsule